RayKnowChina Research Map
Shortlist

Cancer

Pancreatic cancer in Shanghai

上海 胰腺癌

All diseases in Shanghai

19 hospitals in Shanghai

Order: papers led on pancreatic cancer, 2021–2025, then A–Z. Research activity, not a rating of care.

Only hospitals listed for pancreatic cancer: those with enough papers or registered trials on it in the records this site uses. Other hospitals in Shanghai may also treat it. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first.

  1. 212 papers led
  2. 114 papers led
  3. 103 papers led
  4. 88 papers led
  5. 77 papers led
  6. 35 papers led
  7. 19 papers led
  8. 15 papers led
    No open trial led
  9. 14 papers led
    No open trial led
  10. 12 papers led
    No open trial led
  11. 12 papers led
    No open trial led
  12. 11 papers led
  13. 11 papers led
    No open trial led
  14. 7 papers led
    No open trial led
  15. 6 papers led
    No open trial led
  16. 4 papers led
  17. 2 papers led
    No open trial led
  18. 2 papers led
    No open trial led
  19. 0 papers led

Pancreatic cancer in every city Shanghai on the disease page, with the national map

116

open trials on pancreatic cancer with a hospital in Shanghai

Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 18 Nov 2026, with a listed hospital in Shanghai as lead sponsor or study site. 68 of them are led by a hospital in Shanghai. Check the registry for the current status. Whether someone can take part is decided by the study team.

Only trials registered on ClinicalTrials.gov are counted. Trials registered only in China’s own registry (ChiCTR) are not.

  1. Recruiting
    A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
    Phase
    Phase 3
    Started
    2026-02
    Posted
    Registry
    NCT07409272

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesGuangzhou, Shanghai

  2. Recruiting
    CAR-NK Cells (CL-NK-003) in Pancreatic Cancer
    Phase
    Phase 1
    Started
    2026-02
    Posted
    Registry
    NCT07425483

    Age 18 years to 75 years (registered criteria)

    Led by Changhai HospitalShanghai

  3. Recruiting
    AI-Powered Precision Decision-Making for Pancreatic Diseases
    Phase
    Not given
    Started
    2026-03
    Posted
    Registry
    NCT07439757

    Age 18 years to 80 years (registered criteria)

    Led by Changhai HospitalShanghai

  4. Recruiting
    To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.
    Phase
    N/A
    Started
    2026-03
    Posted
    Registry
    NCT07493421

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteShanghai

  5. Recruiting
    Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases
    Phase
    Phase 2
    Started
    2026-03
    Posted
    Registry
    NCT07504471

    Age 18 years to Not stated (registered criteria)

    Led by Ruijin HospitalShanghai

  6. Recruiting
    Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer
    Phase
    Not given
    Started
    2026-05
    Posted
    Registry
    NCT07529626

    Age 18 years to Not stated (registered criteria)

    Led by Zhongshan Hospital, Fudan University; 2 listed hospitals as study sitesChangsha, Shanghai, Xi'an

  7. Recruiting
    Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations
    Phase
    Phase 1/Phase 2
    Started
    2026-07
    Posted
    Registry
    NCT07640295

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 12 listed hospitals as study sitesBeijing, Changsha, Hangzhou, Harbin, Nanjing, Shanghai, Taiyuan, Wuhan, Zhengzhou

  8. Recruiting
    A Study of Dose Escalation of ES502 in Patients With Advanced Pancreatic Cancer
    Phase
    Early phase 1
    Started
    2026-05
    Posted
    Registry
    NCT07649928

    Age 18 years to Not stated (registered criteria)

    Led by Ruijin HospitalShanghai

  9. Recruiting
    A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
    Phase
    Phase 1/Phase 2
    Started
    2026-09
    Posted
    Registry
    NCT07678593

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 9 listed hospitals as study sitesBeijing, Chengdu, Guangzhou, Hangzhou, Shanghai, Shenyang, Wuhan, Xi'an, Zhengzhou

  10. Recruiting
    Patient-Derived Organoid-on-a-Chip Model for Personalized Prediction of Chemotherapy Efficacy in Pancreatic Cancer
    Phase
    Not given
    Started
    2026-02
    Posted
    Registry
    NCT07683845

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteShanghai

  11. Recruiting
    A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer
    Phase
    Early phase 1
    Started
    2026-06
    Posted
    Registry
    NCT07707531

    Age 18 years to Not stated (registered criteria)

    Led by Huashan HospitalShanghai

  12. Recruiting
    A Phase II Study of GFH375 Combined With GFS202A or GFH276 Versus GFH375 in Patients With Previously Treated Locally Advanced Unresectable or Metastatic Pancreatic Cancer Harboring KRAS G12D Mutation
    Phase
    Phase 2
    Started
    2026-08
    Posted
    Registry
    NCT07784374

    Age 18 years to 80 years (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteShanghai

  13. Recruiting
    An Open-Label, Multicenter, Phase IB/II Clinical Study of HRS-7172 in Combination With Antitumor Therapy in Participants With Solid Tumors
    Phase
    Phase 1/Phase 2
    Started
    2026-10
    Posted
    Registry
    NCT07806058

    Age 18 years to 70 years (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteShanghai

  14. Recruiting
    Pancreatic Cancer and Diabetes Mellitus
    Phase
    Not given
    Started
    2025-01
    Posted
    Registry
    NCT06585072

    Age 18 years to Not stated (registered criteria)

    Led by Changzheng HospitalShanghai

  15. Recruiting
    Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer
    Phase
    Phase 3
    Started
    2025-02
    Posted
    Registry
    NCT06752811

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesNanjing, Shanghai

  16. Recruiting
    CAR-NK Cells (CL-NK-001) in Pancreatic Cancer
    Phase
    Phase 1
    Started
    2025-04
    Posted
    Registry
    NCT06816823

    Age 18 years to 70 years (registered criteria)

    Led by Changhai HospitalShanghai

  17. Recruiting
    Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
    Phase
    Phase 1/Phase 2
    Started
    2025-04
    Posted
    Registry
    NCT06821503

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 12 listed hospitals as study sitesBeijing, Harbin, Nanchang, Nanjing, Shanghai, Shenyang, Tianjin, Xi'an, Zhengzhou

  18. Recruiting
    A Study of GC203 TIL in PDCA (RJ)
    Phase
    Early phase 1
    Started
    2025-02
    Posted
    Registry
    NCT06828328

    Age 18 years to 70 years (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteShanghai

  19. Recruiting
    An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer
    Phase
    Phase 2
    Started
    2025-06
    Posted
    Registry
    NCT06938282

    Age 18 years to Not stated (registered criteria)

    Led by Zhongshan Hospital, Fudan UniversityShanghai

  20. Recruiting
    The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial
    Phase
    Phase 2
    Started
    2025-04
    Posted
    Registry
    NCT06946901

    Age 18 years to 80 years (registered criteria)

    Led by Zhongshan Hospital, Fudan University; 1 listed hospital as study siteChangsha, Shanghai

  21. Recruiting
    A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer
    Phase
    Phase 3
    Started
    2025-06
    Posted
    Registry
    NCT06953999

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesHangzhou, Harbin, Shanghai

  22. Recruiting
    Adjuvant Pancreatic Therapy Guided by MRD
    Phase
    N/A
    Started
    2025-06
    Posted
    Registry
    NCT06966440

    Age 18 years to 75 years (registered criteria)

    Led by Ruijin HospitalShanghai

  23. Recruiting
    A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
    Phase
    Phase 2/Phase 3
    Started
    2025-10
    Posted
    Registry
    NCT06989437

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 17 listed hospitals as study sitesBeijing, Dalian, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Lanzhou, Shanghai, Taiyuan, Wenzhou, Xi'an, Zhengzhou

  24. Recruiting
    The Characteristics of Oral Microbiota in Chronic Pancreatitis and Autoimmune Pancreatitis
    Phase
    Not given
    Started
    2025-02
    Posted
    Registry
    NCT07015580

    Age 18 years to Not stated (registered criteria)

    Led by Ruijin HospitalShanghai

  25. Recruiting
    A Multicenter Study of IBI343 Monotherapy Versus Placebo in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, Pancreatic Cancer(G-HOPE-002)
    Phase
    Phase 3
    Started
    2025-07
    Posted
    Registry
    NCT07066098

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteShanghai

  26. Recruiting
    A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
    Phase
    Phase 1
    Started
    2025-07
    Posted
    Registry
    NCT07066657

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 8 listed hospitals as study sitesBeijing, Changsha, Hangzhou, Harbin, Shanghai, Wuhan, Zhengzhou

  27. Recruiting
    A Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer
    Phase
    Not given
    Started
    2025-05
    Posted
    Registry
    NCT07080021

    Age 18 years to 75 years (registered criteria)

    Led by Ruijin HospitalShanghai

  28. Recruiting
    A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer
    Phase
    Phase 2
    Started
    2025-09
    Posted
    Registry
    NCT07114315

    Age 18 years to 80 years (registered criteria)

    Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesShanghai, Tianjin

  29. Recruiting
    Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer
    Phase
    Not given
    Started
    2025-08
    Posted
    Registry
    NCT07117045

    Age 50 years to Not stated (registered criteria)

    Led by Changhai HospitalShanghai

  30. Recruiting
    HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
    Phase
    Phase 2
    Started
    2025-08
    Posted
    Registry
    NCT07131514

    Age 18 years to 80 years (registered criteria)

    Led by Ruijin HospitalShanghai

  31. Recruiting
    PGHD-AI Intelligent Model for the Nutritional Assessment and Intervention of Patients After Radical Surgery for Pancreatic Cancer.
    Phase
    N/A
    Started
    2025-07
    Posted
    Registry
    NCT07167264

    Age 18 years to 80 years (registered criteria)

    Led by Shanghai General HospitalShanghai

  32. Recruiting
    HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer
    Phase
    Phase 3
    Started
    2025-11
    Posted
    Registry
    NCT07232875

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteShanghai

  33. Recruiting
    A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer
    Phase
    Phase 2
    Started
    2025-12
    Posted
    Registry
    NCT07255404

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 11 listed hospitals as study sitesBeijing, Chengdu, Guangzhou, Hangzhou, Kunming, Nanchang, Shanghai, Shenyang, Wuhan, Zhengzhou

  34. Recruiting
    IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
    Phase
    Phase 2
    Started
    2025-12
    Posted
    Registry
    NCT07306273

    Age 18 years to Not stated (registered criteria)

    Led by Ruijin HospitalShanghai

  35. Recruiting
    Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
    Phase
    Phase 2
    Started
    2025-12
    Posted
    Registry
    NCT07306286

    Age 18 years to Not stated (registered criteria)

    Led by Ruijin HospitalShanghai

  36. Recruiting
    A Study on a Predictive Model for Efficacy and Prognosis of Pancreatic Carcinoma Based on Multimodal Data
    Phase
    Not given
    Started
    2025-12
    Posted
    Registry
    NCT07561814

    Age 18 years to Not stated (registered criteria)

    Led by Zhongshan Hospital, Fudan UniversityShanghai

  37. Recruiting
    A IIT Study of 177Lu-DOTA-SNA040
    Phase
    Early phase 1
    Started
    2025-11
    Posted
    Registry
    NCT07595237

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteShanghai

  38. Recruiting
    Study of XNW28012 in Subjects With Metastatic Pancreatic Cancer Who Received Prior Systemic Therapy
    Phase
    Phase 3
    Started
    2025-07
    Posted
    Registry
    NCT07823049

    Age not stated (registered criteria)

    Lead sponsor is not a listed hospital; 36 listed hospitals as study sitesBeijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Nanchang, Nanjing, Shanghai, Shenyang, Taiyuan, Tianjin, Wuhan, Xi'an, Yangzhou, Yinchuan, Zhengzhou

  39. Recruiting
    Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases
    Phase
    Phase 1
    Started
    2024-01
    Posted
    Registry
    NCT06278454

    Age 18 years to 80 years (registered criteria)

    Lead sponsor is not a listed hospital; 6 listed hospitals as study sitesChongqing, Shanghai, Suzhou, Tianjin, Zhengzhou

  40. Recruiting
    PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients
    Phase
    Phase 2
    Started
    2024-06
    Posted
    Registry
    NCT06359275

    Age 18 years to 75 years (registered criteria)

    Led by Fudan University Shanghai Cancer CenterShanghai

  41. Recruiting
    A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer
    Phase
    Phase 2/Phase 3
    Started
    2024-05
    Posted
    Registry
    NCT06361888

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 41 listed hospitals as study sitesBeijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Haikou, Hangzhou, Harbin, Hefei, Jinan, Kunming, Linyi, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Shenzhen, Suzhou, Tianjin, Wenzhou, Wuhan, Xi'an, Xiamen, Zhengzhou

  42. Recruiting
    Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients
    Phase
    Not given
    Started
    2024-04
    Posted
    Registry
    NCT06375473

    Age 18 years to 100 years (registered criteria)

    Led by Peking Union Medical College Hospital; 7 listed hospitals as study sitesBeijing, Hefei, Nanning, Ningbo, Shanghai, Wuhan, Zhengzhou

  43. Recruiting
    A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors
    Phase
    Phase 1
    Started
    2024-04
    Posted
    Registry
    NCT06403735

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 4 listed hospitals as study sitesHarbin, Kunming, Nanchang, Shanghai

  44. Recruiting
    Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma
    Phase
    Phase 1/Phase 2
    Started
    2024-06
    Posted
    Registry
    NCT06427239

    Age 18 years to 75 years (registered criteria)

    Led by Fudan University Shanghai Cancer CenterShanghai

  45. Recruiting
    Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)
    Phase
    Phase 3
    Started
    2024-08
    Posted
    Registry
    NCT06427447

    Age 18 years to 75 years (registered criteria)

    Led by Changhai HospitalShanghai

  46. Recruiting
    Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)
    Phase
    Phase 2
    Started
    2024-05
    Posted
    Registry
    NCT06427460

    Age 18 years to 75 years (registered criteria)

    Led by Changhai HospitalShanghai

  47. Recruiting
    A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
    Phase
    Phase 1/Phase 2
    Started
    2024-06
    Posted
    Registry
    NCT06428409

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 6 listed hospitals as study sitesBeijing, Changsha, Chengdu, Fuzhou, Shanghai, Wuhan

  48. Recruiting
    A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
    Phase
    Phase 1
    Started
    2024-07
    Posted
    Registry
    NCT06465069

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesBeijing, Guangzhou, Shanghai

  49. Recruiting
    Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer
    Phase
    N/A
    Started
    2024-05
    Posted
    Registry
    NCT06478225

    Age 18 years to 75 years (registered criteria)

    Led by Renji HospitalShanghai

  50. Recruiting
    Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer
    Phase
    Early phase 1
    Started
    2024-07
    Posted
    Registry
    NCT06496373

    Age 18 years to Not stated (registered criteria)

    Led by Ruijin HospitalShanghai

  51. Recruiting
    Clinical Study of Lewis Antigen Assay Combined With CA19-9 Assay to Assess Prognosis in Patients With Pancreatic Cancer
    Phase
    N/A
    Started
    2024-08
    Posted
    Registry
    NCT06515587

    Age 18 years to 75 years (registered criteria)

    Led by Shanghai General HospitalShanghai

  52. Recruiting
    Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety
    Phase
    Phase 2
    Started
    2024-07
    Posted
    Registry
    NCT06531278

    Age 18 years to 75 years (registered criteria)

    Led by Shanghai General HospitalShanghai

  53. Recruiting
    Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer
    Phase
    Phase 2
    Started
    2024-09
    Posted
    Registry
    NCT06532617

    Age 18 years to 80 years (registered criteria)

    Led by Shanghai General HospitalShanghai

  54. Recruiting
    A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice
    Phase
    N/A
    Started
    2024-08
    Posted
    Registry
    NCT06541340

    Age 18 years to 75 years (registered criteria)

    Led by Ruijin HospitalShanghai

  55. Recruiting
    Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer
    Phase
    Phase 2
    Started
    2024-10
    Posted
    Registry
    NCT06547736

    Age 18 years to 75 years (registered criteria)

    Led by Fudan University Shanghai Cancer CenterShanghai

  56. Recruiting
    Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors
    Phase
    Early phase 1
    Started
    2024-09
    Posted
    Registry
    NCT06577532

    Age 18 years to Not stated (registered criteria)

    Led by Ruijin HospitalShanghai

  57. Recruiting
    HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
    Phase
    Phase 2
    Started
    2024-12
    Posted
    Registry
    NCT06587061

    Age 18 years to 80 years (registered criteria)

    Led by Ruijin HospitalShanghai

  58. Recruiting
    The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.
    Phase
    Not given
    Started
    2024-09
    Posted
    Registry
    NCT06601010

    Age 18 years to 75 years (registered criteria)

    Led by Ruijin HospitalShanghai

  59. Recruiting
    ImmunoPET Imaging of Pancreatic Cancer
    Phase
    N/A
    Started
    2024-11
    Posted
    Registry
    NCT06602037

    Age 18 years to 70 years (registered criteria)

    Led by Renji HospitalShanghai

  60. Recruiting
    AI-Assisted Non-Contrast CT for Multi-Cancer Screening
    Phase
    N/A
    Started
    2024-10
    Posted
    Registry
    NCT06632886

    Age 18 years to Not stated (registered criteria)

    Led by Changhai HospitalShanghai

  61. Recruiting
    AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort
    Phase
    Not given
    Started
    2024-08
    Posted
    Registry
    NCT06638866

    Age 18 years to Not stated (registered criteria)

    Led by Changhai Hospital; 1 listed hospital as study siteJiaxing, Shanghai

  62. Recruiting
    Target-specific immunoPET Imaging of Digestive System Carcinoma
    Phase
    N/A
    Started
    2024-12
    Posted
    Registry
    NCT06715839

    Age 18 years to 75 years (registered criteria)

    Led by Renji HospitalShanghai

  63. Recruiting
    Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms
    Phase
    Phase 2
    Started
    2024-03
    Posted
    Registry
    NCT06767813

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 5 listed hospitals as study sitesNanjing, Shanghai, Suzhou, Wenzhou, Zhengzhou

  64. Recruiting
    Bile Omics for Diagnosing Indeterminate Biliary Strictures
    Phase
    Not given
    Started
    2024-01
    Posted
    Registry
    NCT07007832

    Age 18 years to 90 years (registered criteria)

    Led by Shanghai General HospitalShanghai

  65. Recruiting
    Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
    Phase
    Phase 1/Phase 2
    Started
    2024-11
    Posted
    Registry
    NCT07433283

    Age 18 years to 80 years (registered criteria)

    Lead sponsor is not a listed hospital; 9 listed hospitals as study sitesBeijing, Changsha, Chengdu, Chongqing, Fuzhou, Haikou, Harbin, Shanghai, Zhengzhou

  66. Recruiting
    Artificial Intelligence-Assisted 4D Dynamic Long-Axial PET Imaging for the Detection of Early Pancreatic Cancer Lesions
    Phase
    Not given
    Started
    2024-11
    Posted
    Registry
    NCT07925125

    Age 18 years to 75 years (registered criteria)

    Led by Ruijin HospitalShanghai

  67. Recruiting
    Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples
    Phase
    Not given
    Started
    2023-03
    Posted
    Registry
    NCT05737953

    Age 18 years to Not stated (registered criteria)

    Led by Changhai HospitalShanghai

  68. Recruiting
    Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors
    Phase
    Not given
    Started
    2023-02
    Posted
    Registry
    NCT05847855

    Age 18 years to Not stated (registered criteria)

    Led by Fudan University Shanghai Cancer Center; 1 listed hospital as study siteChengdu, Shanghai

  69. Recruiting
    A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer
    Phase
    Phase 2
    Started
    2023-05
    Posted
    Registry
    NCT05859750

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 7 listed hospitals as study sitesBeijing, Guangzhou, Hangzhou, Jinan, Shanghai, Wuhan

  70. Recruiting
    Implantation of iodine125-Seeds Combined With Chemotherapy in the Treatment of Metastatic Pancreatic Carcinoma
    Phase
    N/A
    Started
    2023-08
    Posted
    Registry
    NCT05869474

    Age 18 years to 80 years (registered criteria)

    Led by Changhai HospitalShanghai

  71. Recruiting
    A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer
    Phase
    Phase 1
    Started
    2023-07
    Posted
    Registry
    NCT05911217

    Age 18 years to 79 years (registered criteria)

    Lead sponsor is not a listed hospital; 8 listed hospitals as study sitesBeijing, Changsha, Hangzhou, Shanghai, Wuhan, Xi'an, Zhengzhou

  72. Recruiting
    Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer
    Phase
    Early phase 1
    Started
    2023-04
    Posted
    Registry
    NCT05916261

    Age 18 years to Not stated (registered criteria)

    Led by Ruijin HospitalShanghai

  73. Recruiting
    LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic Cancer
    Phase
    N/A
    Started
    2023-10
    Posted
    Registry
    NCT05939063

    Age 18 years to 80 years (registered criteria)

    Led by Fudan University Shanghai Cancer CenterShanghai

  74. Recruiting
    A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer
    Phase
    Phase 2
    Started
    2023-12
    Posted
    Registry
    NCT05969171

    Age 18 years to 75 years (registered criteria)

    Led by Fudan University Shanghai Cancer CenterShanghai

  75. Recruiting
    A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.
    Phase
    Phase 2
    Started
    2023-10
    Posted
    Registry
    NCT06008288

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 29 listed hospitals as study sitesBeijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Nanchang, Nanjing, Qingdao, Shanghai, Shenyang, Tianjin, Wuhan, Xi'an, Zhengzhou

  76. Recruiting
    A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
    Phase
    Phase 2
    Started
    2023-10
    Posted
    Registry
    NCT06111274

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 5 listed hospitals as study sitesChengdu, Harbin, Shanghai, Wuhan

  77. Recruiting
    A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
    Phase
    Phase 1
    Started
    2023-11
    Posted
    Registry
    NCT06131840

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesGuangzhou, Shanghai

  78. Recruiting
    A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection
    Phase
    Not given
    Started
    2023-12
    Posted
    Registry
    NCT06166147

    Age 40 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesShanghai

  79. Recruiting
    Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver Metastasis
    Phase
    N/A
    Started
    2023-10
    Posted
    Registry
    NCT06307080

    Age 18 years to 70 years (registered criteria)

    Led by Shanghai General HospitalShanghai

  80. Recruiting
    Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
    Phase
    Phase 1/Phase 2
    Started
    2023-12
    Posted
    Registry
    NCT06799637

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 17 listed hospitals as study sitesBeijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hangzhou, Hefei, Kunming, Luoyang, Shanghai, Wuhan

  81. Recruiting
    A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
    Phase
    Phase 1
    Started
    2022-10
    Posted
    Registry
    NCT05208762

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesBeijing, Shanghai

  82. Recruiting
    Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation
    Phase
    Phase 1/Phase 2
    Started
    2022-04
    Posted
    Registry
    NCT05288205

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 20 listed hospitals as study sitesBeijing, Changsha, Fuzhou, Guangzhou, Harbin, Hefei, Jinan, Shanghai, Shenyang, Shenzhen, Wuhan, Xiamen, Zhengzhou

  83. Recruiting
    A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
    Phase
    Phase 1
    Started
    2022-06
    Posted
    Registry
    NCT05365581

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 5 listed hospitals as study sitesGuangzhou, Hangzhou, Shanghai, Wuhan, Zhengzhou

  84. Recruiting
    Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer
    Phase
    N/A
    Started
    2022-07
    Posted
    Registry
    NCT05424159

    Age 18 years to 80 years (registered criteria)

    Led by Shanghai Proton and Heavy Ion CenterShanghai

  85. Recruiting
    Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer
    Phase
    Phase 3
    Started
    2022-12
    Posted
    Registry
    NCT05653453

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesHarbin, Shanghai

  86. Recruiting
    Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
    Phase
    Not given
    Started
    2022-09
    Posted
    Registry
    NCT06822413

    Age not stated (registered criteria)

    Led by Second Affiliated Hospital, Zhejiang University; 3 listed hospitals as study sitesHangzhou, Nanchang, Shanghai

  87. Recruiting
    MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer
    Phase
    Not given
    Started
    2022-10
    Posted
    Registry
    NCT07045571

    Age not stated (registered criteria)

    Led by Renji HospitalShanghai

  88. Recruiting
    Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer
    Phase
    Phase 1/Phase 2
    Started
    2021-10
    Posted
    Registry
    NCT04146298

    Age 18 years to 75 years (registered criteria)

    Led by Changhai HospitalShanghai

  89. Recruiting
    Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
    Phase
    Phase 1
    Started
    2021-06
    Posted
    Registry
    NCT04900818

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 10 listed hospitals as study sitesBeijing, Guangzhou, Hangzhou, Harbin, Hefei, Shanghai, Shenyang, Tianjin, Wuhan, Zhengzhou

  90. Recruiting
    A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)
    Phase
    Early phase 1
    Started
    2021-09
    Posted
    Registry
    NCT05098197

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteShanghai

  91. Recruiting
    Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)
    Phase
    Not given
    Started
    2020-12
    Posted
    Registry
    NCT04743479

    Age 50 years to 75 years (registered criteria)

    Led by Changhai HospitalShanghai

  92. Not yet recruiting
    A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer
    Phase
    Phase 3
    Started
    2027-01
    Posted
    Registry
    NCT07138846

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteShanghai

  93. Not yet recruiting
    A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors
    Phase
    Phase 1
    Started
    2026-05
    Posted
    Registry
    NCT07014878

    Age 18 years to 70 years (registered criteria)

    Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesNanjing, Shanghai

  94. Not yet recruiting
    A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer
    Phase
    Phase 3
    Started
    2026-02
    Posted
    Registry
    NCT07383922

    Age 18 years to 80 years (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteShanghai

  95. Not yet recruiting
    Non-Invasive Detection of claudin18.2 in Pancreatic and Gastric/Gastroesophageal Junction Cancer by [68Ga]Ga-NODAGA-SNA014 PET Imaging
    Phase
    Not given
    Started
    2026-04
    Posted
    Registry
    NCT07554742

    Age 18 years to 75 years (registered criteria)

    Led by Ruijin HospitalShanghai

  96. Not yet recruiting
    A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma
    Phase
    Phase 1
    Started
    2026-06
    Posted
    Registry
    NCT07583771

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteShanghai

  97. Not yet recruiting
    HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion
    Phase
    Phase 1
    Started
    2026-07
    Posted
    Registry
    NCT07699757

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteShanghai

  98. Not yet recruiting
    Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic Cancer
    Phase
    Phase 2
    Started
    2026-07
    Posted
    Registry
    NCT07745790

    Age 18 years to Not stated (registered criteria)

    Led by Ruijin HospitalShanghai

  99. Not yet recruiting
    Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast Cancer
    Phase
    Phase 2
    Started
    2026-09
    Posted
    Registry
    NCT07825753

    Age 18 years to 75 years (registered criteria)

    Led by Fudan University Shanghai Cancer CenterShanghai

  100. Not yet recruiting
    Surufatinib in Combination With Iparomlimab and Tuvonralimab Injection and AG Chemotherapy for Neoadjuvant Therapy of HRPC or BRPC
    Phase
    Phase 2
    Started
    2026-09
    Posted
    Registry
    NCT07833241

    Age 18 years to 75 years (registered criteria)

    Led by Zhongshan Hospital, Fudan UniversityShanghai

  101. Not yet recruiting
    HRS-4642 Combined With Antitumor Agents for the Treatment of Perioperative Pancreatic Cancer
    Phase
    Phase 3
    Started
    2026-10
    Posted
    Registry
    NCT07900789

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesBeijing, Shanghai

  102. Not yet recruiting
    A Multicenter, Prospective Single-arm Study of Multimodal Thermal Therapy Combined With Toripalimab and AG Chemotherapy in the Treatment of Advanced Pancreatic Cancer
    Phase
    N/A
    Started
    2026-10
    Posted
    Registry
    NCT07928362

    Age 18 years to 75 years (registered criteria)

    Led by Ruijin Hospital; 4 listed hospitals as study sitesChengdu, Qingdao, Shanghai, Xi'an

  103. Not yet recruiting
    Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer
    Phase
    Phase 2
    Started
    2025-03
    Posted
    Registry
    NCT05562297

    Age 18 years to 75 years (registered criteria)

    Led by Zhongshan Hospital, Fudan UniversityShanghai

  104. Not yet recruiting
    Chemoradiotherapy in Elderly Patients with Locally Advanced Pancreatic Cancer (70+).
    Phase
    Not given
    Started
    2025-02
    Posted
    Registry
    NCT06844773

    Age 70 years to 85 years (registered criteria)

    Led by Zhongshan Hospital, Fudan UniversityShanghai

  105. Not yet recruiting
    A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC
    Phase
    Phase 1
    Started
    2025-07
    Posted
    Registry
    NCT06913218

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteShanghai

  106. Not yet recruiting
    Adebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
    Phase
    Phase 2
    Started
    2025-04
    Posted
    Registry
    NCT06916975

    Age 18 years to 75 years (registered criteria)

    Led by Fudan University Shanghai Cancer CenterShanghai

  107. Not yet recruiting
    Evaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic Cancer
    Phase
    Not given
    Started
    2025-04
    Posted
    Registry
    NCT06941987

    Age 18 years to Not stated (registered criteria)

    Led by Zhongshan Hospital, Fudan UniversityShanghai

  108. Not yet recruiting
    A Real-world Study of Liposomal Irinotecan (Onivyde)-Based Therapy in Patients With Locally Advanced/Metastatic Pancreatic Cancer in China
    Phase
    Not given
    Started
    2025-07
    Posted
    Registry
    NCT07026123

    Age 18 years to Not stated (registered criteria)

    Led by Renji HospitalShanghai

  109. Not yet recruiting
    Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino
    Phase
    Early phase 1
    Started
    2024-01
    Posted
    Registry
    NCT06156267

    Age 18 years to 75 years (registered criteria)

    Led by Fudan University Shanghai Cancer CenterShanghai

  110. Not yet recruiting
    Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer
    Phase
    Phase 2
    Started
    2024-01
    Posted
    Registry
    NCT06166589

    Age 18 years to Not stated (registered criteria)

    Led by Zhongshan Hospital, Fudan UniversityShanghai

  111. Not yet recruiting
    HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer
    Phase
    Phase 3
    Started
    2024-02
    Posted
    Registry
    NCT06217042

    Age 18 years to 75 years (registered criteria)

    Led by Fudan University Shanghai Cancer CenterShanghai

  112. Not yet recruiting
    Newly Emerging Immunotherapy for Pancreatic Cancer Treatment
    Phase
    Phase 1/Phase 2
    Started
    2024-04
    Posted
    Registry
    NCT06370754

    Age 18 years to 75 years (registered criteria)

    Led by Fudan University Shanghai Cancer CenterShanghai

  113. Not yet recruiting
    Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation
    Phase
    Phase 2
    Started
    2024-08
    Posted
    Registry
    NCT06531291

    Age 18 years to 75 years (registered criteria)

    Led by Renji HospitalShanghai

  114. Not yet recruiting
    TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor
    Phase
    Early phase 1
    Started
    2024-09
    Posted
    Registry
    NCT06619886

    Age 18 years to 75 years (registered criteria)

    Led by Shanghai General HospitalShanghai

  115. Not yet recruiting
    Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)
    Phase
    Phase 2
    Started
    2024-10
    Posted
    Registry
    NCT06621095

    Age 18 years to 75 years (registered criteria)

    Led by Renji HospitalShanghai

  116. Enrolling by invitation
    The Differences of Complications Between LPD(Laparoscopic Pancreaticoduodenectomy) and OPD(Open Pancreaticoduodenectomy)
    Phase
    Not given
    Started
    2020-01
    Posted
    Registry
    NCT06685939

    Age 19 years to Not stated (registered criteria)

    Led by Huadong Hospital, Fudan UniversityShanghai

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

Disease research in Shanghai

Each number is papers led on that disease, 2021–2025. “Open” counts open trials the hospital leads. Hospitals A–Z; this is not a ranking.

A blank cell means no papers or trials were found in these records. It does not mean the hospital does not treat that disease.

Papers led and open trials led by hospitals in Shanghai, by disease
CancerBlood disordersOther diseases
HospitalNasopharyngeal carcinomaOesophageal squamous cell carcinomaHepatocellular carcinomaStomach cancerLung cancerPancreatic cancerBreast cancerGliomaHepatoblastomaRetinoblastomaChordomaOsteosarcomaGastrointestinal stromal tumourNeuroblastomaEwing sarcomaMultiple myelomaB-cell acute lymphoblastic leukaemiaAplastic anaemiaHaemophagocytic lymphohistiocytosisLymphomaBeta thalassaemiaHaemophilia AAtypical haemolytic uraemic syndromeThrombotic thrombocytopenic purpuraFanconi anaemiaNeuromyelitis optica spectrum disorderIgG4-related diseaseMyasthenia gravisMoyamoya diseaseWilson diseaseBiliary atresiaCoronary heart diseaseCongenital heart diseaseScoliosisAnti-NMDA receptor encephalitisTakayasu arteritisHepatic echinococcosisIdiopathic pulmonary fibrosisLymphangioleiomyomatosisAmyotrophic lateral sclerosisSpinal muscular atrophyFabry diseasePompe diseaseDuchenne muscular dystrophyBehçet diseaseAlport syndromeIgA nephropathyGaucher diseaseNiemann–Pick disease type COsteogenesis imperfectaPrimary biliary cholangitisPrimary sclerosing cholangitisCongenital diaphragmatic herniaHirschsprung diseaseInherited epidermolysis bullosaHereditary angioedemaFamilial adenomatous polyposisLeber hereditary optic neuropathyMajeed syndromeNGLY1 deficiencyISG15 deficiencyShortlist
Cancer Hospital, Fudan Universitynonenonenonenonenonenone01 opennonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Changhai Hospital海军军医大学第一附属医院(长海医院)2221 open19315 open201 open8812 open101 open7none2none110nonenonenonenonenone9nonenonenonenonenonenone01 opennonenonenonenone417none1none2nonenonenonenonenonenone1none1nonenonenone1none001none0nonenonenonenone
Changzheng Hospital海军军医大学第二附属医院(长征医院)none3151 open171 open4041 opennone10nonenone516402262 opennonenonenone6nonenonenone1nonenonenonenonenonenonenone5none81nonenone2none0nonenonenonenone1none5nonenone21nonenonenonenonenone1nonenonenonenone
Child Health Hospitalnonenonenonenonenonenone26nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone8nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Children Hospital, Fudan Universitynonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Children's Hospital of Fudan University复旦大学附属儿科医院nonenonenonenonenonenonenone115004none111none0none0501 opennone1nonenonenonenone12none213 open5372 open310nonenonenonenone311 open021021none1none1042none0none10none
Dahua Hospitalnonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
East Hospital上海市东方医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0none0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Eastern Hepatobiliary Surgery Hospital海军军医大学第三附属医院(东方肝胆外科医院)nonenone2144 open6none7nonenonenonenonenone41nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone00nonenonenonenonenonenonenonenonenone
Eye & ENT Hospital of Fudan University复旦大学附属眼耳鼻喉科医院324 opennonenonenonenonenonenonenonenone63 open0nonenone51 opennonenonenonenonenone161 opennonenonenonenonenonenonenonenonenonenonenonenone17nonenone0nonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenone1nonenonenone
Fengxian District Central Hospital上海市奉贤区中心医院none3nonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Fifth People's Hospital of Fudan University复旦大学附属上海市第五人民医院nonenonenonenonenone2nonenonenonenone11nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone4nonenonenonenone4nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
First Affiliated Hospital of Naval Medical Universitynonenonenonenonenone6nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
First Rehabilitation Hospital, Tongji University上海市第一康复医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone2nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Fudan University Shanghai Cancer Center复旦大学附属肿瘤医院381 open328 open542 open8817 open24331 open21211 open39090 open15nonenone360none4none0nonenone3318 opennonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenone
Gongli Hospital上海市浦东新区公利医院nonenonenonenonenonenonenonenonenonenonenone00nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Guangming Traditional Chinese Medicine Hospital上海市浦东新区光明中医医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Gynecology Hospital, Fudan University复旦大学附属妇产科医院nonenonenonenonenonenone17nonenonenonenone0none2nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Health Sciences Affiliated Zhoupu Hospital上海市浦东新区周浦医院nonenonenonenonenonenonenonenonenonenonenone111nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone2none1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Huadong Hospital, Fudan University复旦大学附属华东医院none11 opennone41 open42111 opennonenonenonenonenone0nonenonenonenonenonenone06nonenonenonenonenonenonenonenone2nonenone14nonenonenonenonenone0none0nonenonenonenone24none1nonenonenonenonenone1nonenonenonenonenonenonenonenone
Huashan Hospital复旦大学附属华山医院none12621 open226 open62191 open261 open1226 opennonenone420105nonenonenone351 opennone1nonenonenone231 open0314 open17nonenone53none1nonenone7none1011none111none6nonenonenone00nonenone21nonenonenonenonenone
Infant Hospital上海市第一妇婴保健院nonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone30nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Jiading District Anting Hospital上海市嘉定区安亭医院nonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Jiahui International Hospital上海嘉会国际医院nonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Jing'an District Centre Hospital上海市静安区中心医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenone2nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Jinshan Hospital, Fudan University复旦大学附属金山医院nonenonenonenonenonenonenonenonenonenonenone5none1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenone
Longhua Hospital上海中医药大学附属龙华医院none7111344none36nonenonenone14none1nonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenone51 opennone2nonenonenone1nonenonenonenonenonenonenonenone1nonenonenone20nonenonenonenone1nonenonenonenone
Minhang Hospital上海市闵行区中心医院nonenonenone9nonenonenonenonenonenonenone2nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenone
Putuo Hospital上海市普陀区中心医院nonenonenonenonenonenonenonenonenonenonenone0none1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Renji Hospital上海交通大学医学院附属仁济医院22 open81 open1045 open655 open883 open1037 open7620 open251 open3113102none242 opennonenone3232 opennonenone1nonenone111 open231 opennonenone31110020none0none3none1none02none6nonenonenone171 open5nonenonenone2nonenonenonenonenone
Ruijin Hospital上海交通大学医学院附属瑞金医院none221 open353 open9613 open6811 open11418 open11518 open14nonenonenone131 open22022114 opennone29755 open05none0nonenonenonenone2nonenone594 open211nonenone02203nonenonenone142 opennonenonenone0nonenonenonenonenone2nonenonenonenone
Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine上海市第七人民医院nonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai Baoshan Luodian Hospital上海市宝山区罗店医院nonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai Chest Hospital上海市胸科医院none4012 opennonenone41445 opennonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone114nonenonenonenone3nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai Children's Hospital上海市儿童医院nonenonenonenonenonenonenonenonenonenonenone1none61none1none1none40nonenonenonenonenonenonenonenone1none102nonenonenonenonenonenonenonenonenone20000nonenonenonenone2nonenonenonenonenonenonenonenone
Shanghai Children's Medical Center上海交通大学医学院附属上海儿童医学中心nonenonenonenonenonenonenonenone171 opennonenone0none110none81 open5none110nonenonenone2nonenonenonenonenonenonenone971 open2nonenonenonenonenonenone00002 opennonenone30nonenonenonenone221nonenonenonenonenonenone
Shanghai East Hospital, Tongji University同济大学附属东方医院1133637502 open125013none01222113nonenonenone7nonenonenonenone1nonenonenonenonenonenone201 open11nonenonenonenone4none11 opennonenonenonenonenonenone1nonenonenone0nonenonenonenonenonenonenonenonenonenone
Shanghai Eighth People Hospital上海市第八人民医院nonenonenonenonenonenonenonenonenone1none2nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai Electric Power Hospital上海电力医院nonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai Fengxian District Central Hospitalnonenonenonenone0none1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai Fourth People's Hospital同济大学附属上海市第四人民医院nonenonenonenonenonenonenonenone1nonenone1nonenonenone31 opennonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai General Hospital上海市第一人民医院53361 open271 open494 open357 open6213none152420none200none118 opennone0nonenonenonenonenonenonenonenonenone254none11none1none1nonenonenonenonenonenone0nonenonenonenone0nonenonenonenonenone2nonenonenone
Shanghai Jiading Central Hospital上海市嘉定区中心医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenone
Shanghai Mengchao Cancer Hospitalnonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai Mental Health Center上海市精神卫生中心nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai Municipal Hospital, Shanghai University of Traditional Chinese Medicine上海市中医医院nonenonenonenone28nonenonenonenonenonenone2none10nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenone11nonenonenonenonenonenonenonenonenone
Shanghai Ninth People's Hospital上海交通大学医学院附属第九人民医院54nonenone3311279none29none1512nonenonenonenonenone221 opennone1nonenone1nonenonenonenonenonenone1502none0none4nonenone0nonenone11none0nonenone10nonenone01nonenone1nonenonenone
Shanghai Proton and Heavy Ion Center上海市质子重离子医院0none2none63 open01 open13 open2nonenone0none0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai Pudong Hospital上海市浦东医院nonenonenonenonenone2106none0none0nonenonenone10nonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai Pudong New Area People's Hospital上海市浦东新区人民医院nonenonenonenonenonenonenonenonenonenonenone0none00nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai Pulmonary Hospital上海市肺科医院none5nonenone39443 opennonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenone71 opennonenonenonenonenonenone0none1nonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai Putuo District Liqun Hospital上海市普陀区利群医院nonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai Sixth People's Hospital上海市第六人民医院3027214315438nonenone0350411nonenonenonenonenonenonenonenonenone2nonenonenonenonenone112nonenonenonenone2none4nonenonenone0none00nonenone711nonenonenonenone0nonenonenonenone
Shanghai Songjiang District Central Hospital上海市松江区中心医院nonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai Stomatological Hospital上海市口腔医院nonenonenonenonenonenonenonenonenonenonenone2nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai Tenth People's Hospital上海市第十人民医院none32721611444123none0210205nonenonenone10nonenonenonenonenonenonenonenonenonenonenone27nonenonenone2none2nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai Tong Ren Hospital上海市同仁医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shanghai Xuhui Central Hospital上海徐汇中心医院nonenonenonenonenonenonenonenone1nonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenone0nonenonenone0nonenonenonenonenonenonenonenonenonenone
Shibei Hospital上海市静安区市北医院nonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Shuguang Hospital上海中医药大学附属曙光医院nonenone20nonenonenonenonenonenonenonenone1none00nonenonenonenonenonenone1nonenone1nonenonenonenonenonenonenonenone2nonenonenone3nonenonenonenonenonenonenonenone3nonenonenone11nonenonenonenonenonenonenonenonenone
Tongji Hospital同济大学附属同济医院none3none1730nonenone9nonenonenone212none21 open01 open0none185 opennonenonenonenonenonenonenonenonenonenonenone92nonenonenonenone2none0nonenonenonenone0none0nonenonenonenone0nonenonenonenonenonenonenonenonenone
Xinhua Hospital上海交通大学医学院附属新华医院nonenone21243212283215none401702nonenonenone7nonenonenonenonenonenonenone2none297363 open330nonenone0none10100001 open221 open1010364nonenonenonenonenonenone
Xinshijie Zhongxing Eye Hospital上海新视界中兴眼科医院nonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Yangpu Hospital上海市杨浦区中心医院nonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Yangzhi Rehabilitation Hospital, Tongji University上海市养志康复医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone2nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Yueyang Hospital, Shanghai University of Traditional Chinese Medicine上海中医药大学附属岳阳中西医结合医院nonenonenonenonenonenonenonenonenonenonenone1nonenonenone3nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone2nonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenone1nonenonenonenone1nonenonenonenone
Zhabei Central Hospital上海市静安区闸北中心医院nonenonenonenonenonenonenonenonenonenonenone0nonenonenone7nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Zhongshan Hospital, Fudan University复旦大学附属中山医院3568 open40816 open1348 open1864 open779 open441 open193none052802234 opennonenonenone142 open1nonenonenonenone0411 opennonenonenone10914 open30none0332 opennone313nonenonenone12none4nonenone10nonenonenone1none0nonenonenonenone
Zhongshan-Xuhui Hospital上海市徐汇区中心医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone

Column labels are short names. Choose one to open that disease in Shanghai.

Other cities nearby

Straight-line distance from the city centre; counts are hospitals listed for pancreatic cancer.

Counts are listed hospitals only, not every hospital in each city.

Where these numbers come from

Papers

English-language PubMed papers, 2021–2025, where the first or last author lists the hospital first. Definitions

Trials

ClinicalTrials.gov records with the hospital as lead sponsor or site, as of 8 Nov 2026. Search Shanghai on ClinicalTrials.gov

Locations

Locations are shown at city centres. Check the hospital’s website for its address.

Suggest a correctionDownload the data